Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C
Introduction and Objective: This study aimed to evaluate serum concentration of MMP-2 and -9 in different etiologies of liver disease also according to fibrosis stages. Materials and methods: Cross-sectional multicentric study, including subjects with no alcoholic fatty liver disease (NAFLD), chroni...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268122002101 |
| _version_ | 1811320249165807616 |
|---|---|
| author | M Lemus-Peña D Montes de Oca-Ángeles M Hernandez-Santillan A Hernandez-Barragan D Santana-Vargas M Martinez-Castillo Z Medina-Avila A Torre-Delgadillo JL Pérez-Hernández F Higuera-De la Tijera P Cordero-Pérez L Muñoz-Espinosa D Kershenobich G Gutiérrez-Reyes |
| author_facet | M Lemus-Peña D Montes de Oca-Ángeles M Hernandez-Santillan A Hernandez-Barragan D Santana-Vargas M Martinez-Castillo Z Medina-Avila A Torre-Delgadillo JL Pérez-Hernández F Higuera-De la Tijera P Cordero-Pérez L Muñoz-Espinosa D Kershenobich G Gutiérrez-Reyes |
| author_sort | M Lemus-Peña |
| collection | DOAJ |
| description | Introduction and Objective: This study aimed to evaluate serum concentration of MMP-2 and -9 in different etiologies of liver disease also according to fibrosis stages. Materials and methods: Cross-sectional multicentric study, including subjects with no alcoholic fatty liver disease (NAFLD), chronic Hepatitis C (CHC), alcohol cirrhosis (CiOH) and alcoholism (OH), groups with alcohol drinking habits were classified according to OMS criteria, with clinical and biochemical evidence of alcoholic liver disease (ALD). Transitional elastography (Fibroscan) was performed in NAFLD and CHC, considering mild fibrosis (FL: F0, F1, F2) and severe fibrosis (FA: F3, F4). As controls, subjects without alcohol consumption (CT) were recruited. Multiplex®-MERCK© was used for MMP-2 and -9 quantification. Statistical analysis was performed by Mann Whitney-U test, p<0.05, with SPSS V.22. Results: The groups included were: 27 NAFLD (mild fibrosis: F0, F1, F2), 36 NAFLD (severe fibrosis: F3, F4), 48 CHC (mild fibrosis: F0, F1, F2), 54 CHC (severe fibrosis: F3, F4), 45 (CiOH), 99 (OH), and 138 CT. Both gelatinases, MMP-2 y MMP-9, were found elevated in CHC (mild and severe fibrosis) vs. CT; and decreased in OH, CiOH, HGNA (mild and severe fibrosis) vs. CT, plus there are significant differences between all etiologies, p<0.001. Discussion: In patients with CHC, MMP-2 y -9 serum concentration increases, particularly in severe fibrosis stages, although it has no effect on ECM (extracellular matrix) degradation, as they are inactive. Nevertheless, there is a significant decrease in these gelatinases in ALD and NAFLD. Conclusions: MMP-2 y MMP-9 module depends on the etiological agent involved, which can be useful for the differential diagnosis of liver diseases. Funding: This work was partially financed by CONACyT SALUD-2016-272579 (GRG) and PAPIIT- UNAM TA200515 (GRG). Declaration of interest: The authors declare no potential conflicts of interest. |
| first_indexed | 2024-04-13T12:55:47Z |
| format | Article |
| id | doaj.art-6342f71497f44adaa40351544762ae92 |
| institution | Directory Open Access Journal |
| issn | 1665-2681 |
| language | English |
| last_indexed | 2024-04-13T12:55:47Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj.art-6342f71497f44adaa40351544762ae922022-12-22T02:46:03ZengElsevierAnnals of Hepatology1665-26812022-12-0127100868Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis CM Lemus-Peña0D Montes de Oca-Ángeles1M Hernandez-Santillan2A Hernandez-Barragan3D Santana-Vargas4M Martinez-Castillo5Z Medina-Avila6A Torre-Delgadillo7JL Pérez-Hernández8F Higuera-De la Tijera9P Cordero-Pérez10L Muñoz-Espinosa11D Kershenobich12G Gutiérrez-Reyes13Liver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoLiver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoLiver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoLiver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoDepartment of Gastroenterology. General Hospital of México “Dr. Eduardo Liceaga.” México City. MéxicoLiver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoLiver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoDepartment of Gastroenterology. General Hospital of México “Dr. Eduardo Liceaga.” México City. MéxicoDepartment of Gastroenterology. General Hospital of México “Dr. Eduardo Liceaga.” México City. MéxicoDepartment of Gastroenterology. General Hospital of México “Dr. Eduardo Liceaga.” México City. MéxicoUniversitary Hospital “Dr. José Eluterio González”. School of Medicine. UANL. Nuevo Leon. MexicoUniversitary Hospital “Dr. José Eluterio González”. School of Medicine. UANL. Nuevo Leon. MexicoNational Institute of Medical Sciences and Nutrition “Salvador Zubirán.” México City. MexicoLiver, Pancreas and Motility Laboratory. Unit of Research in Experimental Medicine. School of Medicine. UNAM. Mexico City. MexicoIntroduction and Objective: This study aimed to evaluate serum concentration of MMP-2 and -9 in different etiologies of liver disease also according to fibrosis stages. Materials and methods: Cross-sectional multicentric study, including subjects with no alcoholic fatty liver disease (NAFLD), chronic Hepatitis C (CHC), alcohol cirrhosis (CiOH) and alcoholism (OH), groups with alcohol drinking habits were classified according to OMS criteria, with clinical and biochemical evidence of alcoholic liver disease (ALD). Transitional elastography (Fibroscan) was performed in NAFLD and CHC, considering mild fibrosis (FL: F0, F1, F2) and severe fibrosis (FA: F3, F4). As controls, subjects without alcohol consumption (CT) were recruited. Multiplex®-MERCK© was used for MMP-2 and -9 quantification. Statistical analysis was performed by Mann Whitney-U test, p<0.05, with SPSS V.22. Results: The groups included were: 27 NAFLD (mild fibrosis: F0, F1, F2), 36 NAFLD (severe fibrosis: F3, F4), 48 CHC (mild fibrosis: F0, F1, F2), 54 CHC (severe fibrosis: F3, F4), 45 (CiOH), 99 (OH), and 138 CT. Both gelatinases, MMP-2 y MMP-9, were found elevated in CHC (mild and severe fibrosis) vs. CT; and decreased in OH, CiOH, HGNA (mild and severe fibrosis) vs. CT, plus there are significant differences between all etiologies, p<0.001. Discussion: In patients with CHC, MMP-2 y -9 serum concentration increases, particularly in severe fibrosis stages, although it has no effect on ECM (extracellular matrix) degradation, as they are inactive. Nevertheless, there is a significant decrease in these gelatinases in ALD and NAFLD. Conclusions: MMP-2 y MMP-9 module depends on the etiological agent involved, which can be useful for the differential diagnosis of liver diseases. Funding: This work was partially financed by CONACyT SALUD-2016-272579 (GRG) and PAPIIT- UNAM TA200515 (GRG). Declaration of interest: The authors declare no potential conflicts of interest.http://www.sciencedirect.com/science/article/pii/S1665268122002101 |
| spellingShingle | M Lemus-Peña D Montes de Oca-Ángeles M Hernandez-Santillan A Hernandez-Barragan D Santana-Vargas M Martinez-Castillo Z Medina-Avila A Torre-Delgadillo JL Pérez-Hernández F Higuera-De la Tijera P Cordero-Pérez L Muñoz-Espinosa D Kershenobich G Gutiérrez-Reyes Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C Annals of Hepatology |
| title | Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C |
| title_full | Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C |
| title_fullStr | Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C |
| title_full_unstemmed | Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C |
| title_short | Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C |
| title_sort | serum determination of mmp 2 and mmp 9 in chronic liver disease according to alcohol consumption non alcoholic fatty liver disease and hepatitis c |
| url | http://www.sciencedirect.com/science/article/pii/S1665268122002101 |
| work_keys_str_mv | AT mlemuspena serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT dmontesdeocaangeles serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT mhernandezsantillan serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT ahernandezbarragan serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT dsantanavargas serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT mmartinezcastillo serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT zmedinaavila serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT atorredelgadillo serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT jlperezhernandez serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT fhigueradelatijera serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT pcorderoperez serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT lmunozespinosa serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT dkershenobich serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc AT ggutierrezreyes serumdeterminationofmmp2andmmp9inchronicliverdiseaseaccordingtoalcoholconsumptionnonalcoholicfattyliverdiseaseandhepatitisc |